ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,937 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryPetit-LancyTelix Pharmaceuticals (Switzerland) Sàrl
Telix Pharmaceuticals (Switzerland) Sàrl Logo
Verified· 2 sourcesTrust Score
Summary

About the company

The core activity of Telix Pharmaceuticals is the development and manufacture of biopharmaceutical products, in particular targeted radiation products for the diagnosis and treatment of cancer and rare diseases.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Telix Pharmaceuticals (Switzerland) Sàrl

✓ Offered5
Radiopharmaceutical diagnostics and therapies
Targeted radiopharmaceuticals for oncology and rare diseases, including therapeutic and diagnostic (‘theranostic’) products, paired imaging agents, and personalised radiation-based treatment approaches.
Prostate imaging products (Illuccix® & Gozellix®)
Imaging agents for men with prostate cancer, including Illuccix® and Gozellix®, used for PET-based staging and other prostate-cancer imaging indications.
Clinical studies
Clinical studies for investigational radiopharmaceutical therapies, including the ProstACT Global Phase 3 study and other trials across prostate, kidney, brain, musculoskeletal and hematology programs.
Research and development
Research on targeted alpha therapy, immuno-oncology, tumour microenvironment, artificial intelligence and surgical solutions to expand future radiopharmaceutical applications.
Partnerships for programs and platforms
Partnership opportunities around Telix programs and platform technologies, including collaboration on therapeutic, diagnostic and medtech development.
Trust & reputation

ranQ Trust Score of Telix Pharmaceuticals (Switzerland) Sàrl: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of October 2026

Without public customer reviews the score stays capped.

Telix Pharmaceuticals (Switzerland) Sàrl has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Telix Pharmaceuticals (Switzerland) Sàrl scores 89.7 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.100.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.82.07%
Telix Pharmaceuticals (Switzerland) Sàrl scores 85.0 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).85.022%
Telix Pharmaceuticals (Switzerland) Sàrl scores 100.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.100.04%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Telix Pharmaceuticals (Switzerland) Sàrl reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Telix Pharmaceuticals (Switzerland) Sàrl has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Telix Pharmaceuticals (Switzerland) Sàrl in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Telix Pharmaceuticals (Switzerland) Sàrl by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Telix Pharmaceuticals (Switzerland) Sàrl to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Avenue des Morgines 12
1213 Petit-Lancy
Opening hours
Mon
09:00 - 16:00
Tue
09:00 - 16:00
Wed
09:00 - 16:00
Thu
09:00 - 16:00
Fri
09:00 - 16:00
Sat
Closed
Sun
Closed

At a glance

Legal form
Limited Liability Company
UID
CHE-101.107.090
Founded
1999 · 27 years
Last commercial register change
February 24, 2026
Employees
21 to 50
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.88.06%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    RF
    ReMedys Foundation
    Geneva
    AT
    Atopia Therapeutics SA
    Geneva
    NS
    NovImmune SA
    Plan-Les-Ouates
    AS
    argenx Switzerland SA
    Châtelaine
    MM
    MMV MEDICINES FOR MALARIA VENTURE
    Cointrin
    SS
    STALICLA SA
    Geneva
    AS
    Ageronix SA
    Carouge Ge
    KB
    KBI Biopharma SA
    Plan-Les-Ouates